LifeStance Health Group, Inc. (LFST)
USD 7.09
(-5.21%)
USD 7.09
(-5.21%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 804.27 Million USD | 22.76% |
| 2022 | 655.14 Million USD | 71.47% |
| 2021 | 382.08 Million USD | -33.19% |
| 2020 | 571.89 Million USD | 27.9% |
| 2019 | 447.13 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 677.31 Million USD | -15.79% |
| 2024 Q2 | 689.32 Million USD | 1.77% |
| 2023 Q2 | 676.04 Million USD | 3.46% |
| 2023 FY | 804.27 Million USD | 22.76% |
| 2023 Q1 | 653.43 Million USD | -0.26% |
| 2023 Q4 | 804.27 Million USD | 11.7% |
| 2023 Q3 | 720.01 Million USD | 6.51% |
| 2022 Q3 | 448.15 Million USD | 2.47% |
| 2022 FY | 655.14 Million USD | 71.47% |
| 2022 Q2 | 437.37 Million USD | 5.17% |
| 2022 Q1 | 415.86 Million USD | 8.84% |
| 2022 Q4 | 655.14 Million USD | 46.19% |
| 2021 Q1 | 652.27 Million USD | 14.05% |
| 2021 FY | 382.08 Million USD | -33.19% |
| 2021 Q4 | 382.08 Million USD | 3.3% |
| 2021 Q3 | 369.88 Million USD | 0.02% |
| 2021 Q2 | 369.79 Million USD | -43.31% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 571.89 Million USD | 0.0% |
| 2020 FY | 571.89 Million USD | 27.9% |
| 2019 FY | 447.13 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 67.454% |
| Addus HomeCare Corporation | 317.73 Million USD | -153.131% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -520.776% |
| Amedisys, Inc. | 940.38 Million USD | 14.474% |
| American Oncology Network, Inc. | 368.72 Million USD | -118.123% |
| Astrana Health, Inc. | 522.59 Million USD | -53.901% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 54.421% |
| IMAC Holdings, Inc. | 1.89 Million USD | -42302.542% |
| biote Corp. | 191.84 Million USD | -319.241% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -1013.155% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -290.57% |
| COMPASS Pathways plc | 50.24 Million USD | -1500.774% |
| DocGo Inc. | 185.28 Million USD | -334.085% |
| The Ensign Group, Inc. | 2.68 Billion USD | 69.992% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -132.07% |
| InnovAge Holding Corp. | 247.85 Million USD | -224.498% |
| Assure Holdings Corp. | 22.84 Million USD | -3419.966% |
| The Joint Corp. | 62.37 Million USD | -1189.34% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -21003.196% |
| ModivCare Inc. | 1.61 Billion USD | 50.078% |
| NewGenIvf Group Limited | 1.24 Million USD | -64686.074% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -7169.333% |
| Option Care Health, Inc. | 1.9 Billion USD | 57.818% |
| P3 Health Partners Inc. | 427.3 Million USD | -88.221% |
| P3 Health Partners Inc. | 427.3 Million USD | -88.221% |
| The Pennant Group, Inc. | 394.17 Million USD | -104.04% |
| Surgery Partners, Inc. | 3.65 Billion USD | 78.008% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -88275.096% |
| Talkspace, Inc. | 23.57 Million USD | -3311.567% |
| Talkspace, Inc. | 23.57 Million USD | -3311.567% |
| The Oncology Institute, Inc. | 162.39 Million USD | -395.266% |
| The Oncology Institute, Inc. | 162.39 Million USD | -395.266% |